Primus Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPrimus Pharmaceuticals

Primus Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Impoyz	Clobetasol	2017-11-28	2025-2035	Inflammation , Dermatitis , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses
Metaxalone	Metaxalone	2015-06-01	2026	Myositis , Pain , Muscle spasticity , Muscle cramp , Spasm , Muscle rigidity
Sernivo	Betamethasone	2016-02-05	2027-2039	Psoriasis , Atopic dermatitis , Pruritus ani , Inflammation , Facial dermatoses , Seborrheic dermatitis , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Mycoses , Oral candidiasis , Vulvovaginal candidiasis , Tinea pedis , Cutaneous candidiasis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

spinal stenosis

,

,

cognitive dysfunction

,

,

healthy volunteers/patients

healthy volunteers/patients

Clobetasol propionate

healthy volunteers/patients

Betamethasone dipropionate

healthy volunteers/patients

,

,

,

,

,

esophageal neoplasms

,

colorectal neoplasms

,

,

acute lung injury

,

healthy volunteers/patients

,

coronavirus infections

,

therapeutic equivalency

,

,

metabolic syndrome

,

,

,

insulin resistance

,

,

,

,

,

,

,

,

,

,

,

,

,

,

,

muscle weakness

,

,

,

,

non-alcoholic fatty liver disease

,

alcoholic fatty liver

,

metabolic bone diseases

,

,

,

breast neoplasms

,

cardiovascular diseases

,

,

rheumatoid arthritis

,

heart disease risk factors

,

,

drug-related side effects and adverse reactions

,

ulcerative colitis

,

peripheral nervous system diseases

,

venous insufficiency

,

,

,

,

,

venous thrombosis

,

postthrombotic syndrome

,

,

polycystic ovary syndrome

,

,

,

,

body weight changes

,

,

exercise tolerance

,

,

,

,

type 2 diabetes mellitus

,

,

acid-base imbalance

,

psychological power

,

oxidative stress

,

,

telerehabilitation

,

pelvic floor disorders

,

,

,

,

postmenopausal osteoporosis

,

,

,

biological availability

,

prediabetic state

,

diabetic neuropathies

,

,

congenital abnormalities

,

vascular malformations

,

,

systemic scleroderma

,

diffuse scleroderma

,

ovarian hyperstimulation syndrome

,

vascular diseases

,

obstructive sleep apnea

,

,

,

,

cognitive dysfunction

,

dental pulp exposure

,

dental pulp capping

,

,

blood circulation

,

replacement arthroplasty knee

,

,

hematologic neoplasms

,

,

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

,

,

colorectal neoplasms

,

healthy volunteers/patients

,

non-small-cell lung carcinoma

,

,

neoplasm metastasis

,

thyroid diseases

,

laryngeal diseases

,

prostatic neoplasms

,

head and neck neoplasms

,

postmenopausal osteoporosis

,

,

rheumatoid arthritis

,

metabolic bone diseases

Bos taurus adrenal cortex corticosteroids

,

colorectal neoplasms

,

,

hepatocellular carcinoma

,

liver neoplasms

,

chronic renal insufficiency

,

kidney diseases

,

type 2 diabetes mellitus

,

diabetes mellitus

,

atopic dermatitis

,

,

duchenne muscular dystrophy

,

muscular dystrophies

,

knee osteoarthritis

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use